SPY421.97-0.14 -0.03%
DIA338.65-2.11 -0.62%
IXIC14,161.35+121.67 0.87%

BRIEF-Biogen And Capsigen Announce Collaboration To Discover And Develop Novel AAV Capsids For Targeted CNS And Neuromuscular Disorders

05/10/2021 18:19
BRIEF-Biogen And Capsigen Announce Collaboration To Discover And Develop Novel AAV Capsids For Targeted CNS And Neuromuscular Disorders

- Biogen Inc BIIB.O:

  • BIOGEN INC - BIOGEN AND CAPSIGEN ANNOUNCE COLLABORATION TO DISCOVER AND DEVELOP NOVEL AAV CAPSIDS FOR TARGETED CNS AND NEUROMUSCULAR DISORDERS

  • BIOGEN INC - CAPSIGEN TO RECEIVE A $15 MILLION UPFRONT PAYMENT AND IS ELIGIBLE TO RECEIVE POTENTIAL RESEARCH, DEVELOPMENT AND COMMERCIAL MILESTONE PAYMENTS

  • BIOGEN - WILL RECEIVE AN EXCLUSIVE LICENSE UNDER CAPSIGEN'S PROPRIETARY TECHNOLOGY FOR AN UNDISCLOSED NUMBER OF CNS AND NEUROMUSCULAR DISEASE TARGETS

  • BIOGEN - CAPSIGEN IS ELIGIBLE TO RECEIVE UP TO $42 MILLION IN POTENTIAL RESEARCH MILESTONES

  • BIOGEN - CAPSIGEN IS ALSO ELIGIBLE TO RECEIVE UP TO ADDITIONAL $1.25 BILLION IN POTENTIAL DEVELOPMENT, COMMERCIAL PAYMENTS

Source text for Eikon: ID:nGNXhB2MQ

Further company coverage: BIIB.O


(([email protected];))